ZetolaNFrancisJSNuermbergerELCommunity-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis2005;5:275–86.
2.
AllenU. Public health implications of MRSA in Canada. CMAJ2006;175:161–2.
3.
HawkesMBartonMConlyJCommunity-associated MRSA: superbug at our doorstep. CMAJ2007;176:54–6.
4.
BartonMHawkesMMooreDGuidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: a perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol2006;17 (Suppl C):4C.
5.
NicolleL. Community-acquired MRSA: a practitioner's guide. CMAJ2006;175 (2):145–6.
6.
GrimSARappRPMartinCATrimethoprimsulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy2005;25:253–64.
7.
MoelleringRC. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med.2006;144:368–70.
